Skip to main content

Table 3 Procedural Results

From: Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions

Outcomes Overall population Matched population
PCB (n = 32) Non-PCB (n = 74) p PCB (n = 25) Non-PCB (n = 25) p
Pre-dilatation 32 (100.0) 74 (100.0) 1.000 25 (100.0) 25 (100.0) 1.000
Balloon diameter of pre-dilatation, (mm) 5.27 ± 0.54 5.31 ± 0.64 0.729 5.22 ± 0.46 5.44 ± 0.56 0.137
Balloon/artery ratio of pre-dilatation 0.94 ± 0.11 0.96 ± 0.12 0.307 0.93 ± 0.10 0.99 ± 0.11 0.052
Balloon pressure of pre-dilatation, (atm) 11.5 ± 3.3 11.1 ± 3.0 0.526 11.5 ± 3.5 10.8 ± 2.7 0.441
The detail of PCB
 Diameter, (mm) 5.63 ± 0.79 5.60 ± 0.82
 Total length, (mm) 133.8 ± 52.7 137.6 ± 52.1
 Inflation time, (sec) 72.2 ± 32.2 74.4 ± 35.8
 Dilatation pressure, (atm) 9.1 ± 3.1 9.5 ± 3.4
Bail-out stenting 0 (0.0) 20 (27.0) < 0.001 0 (0.0) 7 (28.0) 0.001
Complications
 Slow flow 3 (9.4) 5 (6.8) 0.695 2 (4.0) 1 (3.0) 1.000
 Distal embolization 2 (6.3) 3 (4.1) 0.637 2 (4.0) 0 (0.0) 0.490
 Vessel perforation 0 (0.0) 0 (0.0) 1.000 0 (0.0) 0 (0.0) 1.000
  1. Categorical variables are expressed as number and percentage. Continuous variables are indicated as mean ± SD
  2. PCB indicates paclitaxel-coated balloon